MedPath

MEBENDAZOLE

MEBENDAZOLE TABLETS, USP 100 mg9107

Approved
Approval ID

fa778759-2b9a-4446-ba06-d3c486019e79

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 29, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

mebendazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-3732
Application NumberANDA073580
Product Classification
M
Marketing Category
C73584
G
Generic Name
mebendazole
Product Specifications
Route of AdministrationORAL
Effective DateMarch 30, 2011
FDA Product Classification

INGREDIENTS (10)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MEBENDAZOLEActive
Quantity: 100 mg in 1 1
Code: 81G6I5V05I
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TY
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MEBENDAZOLE - FDA Drug Approval Details